- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refraktære faste tumorer in China
I alt 2784 resultater
-
3D Medicines (Beijing) Co., Ltd.Aktiv, ikke rekrutterende
-
Toshihiko DoiMerck Sharp & Dohme LLC; Oncolys BioPharma IncAfsluttet
-
Kyowa Kirin Co., Ltd.Ono Pharmaceutical Co. LtdAfsluttet
-
Beijing Boren HospitalAfsluttetAvanceret solid tumor | Recidiverende/refraktær lymfomKina
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UkendtAvanceret solid tumorKina
-
Jacobio Pharmaceuticals Co., Ltd.Merck Sharp & Dohme LLCRekruttering
-
Abbisko Therapeutics Co, LtdRekrutteringSolid tumorForenede Stater, Kina
-
Shanghai Henlius BiotechRekruttering
-
Sichuan UniversityRekruttering
-
Hutchison Medipharma LimitedUkendtSolid tumor, voksenKina
-
Sun Yat-sen UniversityRekrutteringSolid tumor | Avanceret kræftKina
-
Daiichi SankyoMerck Sharp & Dohme LLCRekrutteringAvanceret solid tumor | Ondartet fast tumorForenede Stater, Japan
-
The First Affiliated Hospital of Xiamen UniversityRekrutteringRefraktær fast tumorKina
-
The First Affiliated Hospital of Xiamen UniversityRekrutteringRefraktær fast tumorKina
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Afsluttet
-
Novartis PharmaceuticalsAfsluttetAvanceret solid tumorJapan
-
TCRx Therapeutics Co.LtdRekrutteringRefraktære faste tumorer | Recidiverende solide tumorer | TCR-T cellerKina
-
Eisai Co., Ltd.Afsluttet
-
Chengdu Zenitar Biomedical Technology Co., LtdIkke rekrutterer endnuAvanceret solid tumorKina
-
Tarapeutics Science Inc.Rekruttering
-
Guangzhou Sinogen Pharmaceutical Co., LtdParexelRekrutteringAvanceret solid tumorKina, Taiwan
-
InxMed (Shanghai) Co., Ltd.InventisBio Co., LtdRekruttering
-
Jiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterende
-
Novartis PharmaceuticalsAfsluttet
-
Guangdong Fapon Biopharma Inc.RekrutteringAvanceret solid tumorKina
-
TransThera Sciences (Nanjing), Inc.Ikke rekrutterer endnu
-
Ascentage Pharma Group Inc.RekrutteringAvanceret solid tumorKina
-
Haihe Biopharma Co., Ltd.Shanghai Institute of Materia Medica, Chinese Academy of SciencesAfsluttetAvanceret solid tumorKina
-
Jiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.Tilmelding efter invitation
-
Tianjin Medical University Second HospitalRekrutteringSolid tumor | EGFR amplifikationKina
-
Noile-Immune Biotech, IncRekruttering
-
HighField Biopharmaceuticals CorporationTigermed Consulting Co., LtdRekrutteringSolid tumor, voksenKina
-
Beijing Bio-Targeting Therapeutics Technology Co...Ikke rekrutterer endnu
-
Shenzhen Geno-Immune Medical InstituteRekruttering
-
Ningbo Cancer HospitalUkendtAvanceret kræft | Solid tumor, voksenKina
-
Suzhou Genhouse Bio Co., Ltd.Ikke rekrutterer endnuPatient med avanceret solid tumorKina
-
Second Affiliated Hospital of Soochow UniversityIkke rekrutterer endnu
-
Beijing Mabworks Biotech Co., Ltd.RekrutteringAvanceret eller metastatisk solid tumorKina
-
Guangzhou Concord Cancer CenterSun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Varian, a Siemens...AfsluttetSolid tumor | Protonterapi | StråleterapiKina
-
Guangzhou Sinogen Pharmaceutical Co., LtdParexel; ClinChoice Enterprise Management (Shanghai) LimitedRekrutteringAvanceret solid tumorForenede Stater, Kina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Aktiv, ikke rekrutterendeAvanceret solid tumorKina
-
Chugai PharmaceuticalRekrutteringSolid tumorForenede Stater, Japan
-
Etern BioPharma (Shanghai) Co., LtdRekrutteringAvanceret solid tumorKina
-
SmartNuclide BiopharmaRekruttering
-
Hoffmann-La RocheAktiv, ikke rekrutterendeSolid tumorKorea, Republikken, Kina, Frankrig, Portugal, Spanien, Brasilien, Tyskland, Italien, Peru, Den Russiske Føderation, Japan, Ukraine, Costa Rica, Mexico, Polen
-
Abbisko Therapeutics Co, LtdRekrutteringSolid tumorForenede Stater, Kina
-
Hangzhou Adcoris Biopharmacy Co., LtdTilmelding efter invitationHER2-positiv avanceret solid tumorKina
-
Daiichi Sankyo Co., Ltd.RekrutteringAvanceret solid tumorJapan
-
Eli Lilly and CompanyAfsluttetAvanceret solid tumorJapan